1. Home
  2. SMJF vs CRBU Comparison

SMJF vs CRBU Comparison

Compare SMJF & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SMJ International Holdings Inc. Class A Ordinary Shares

SMJF

SMJ International Holdings Inc. Class A Ordinary Shares

N/A

Current Price

$5.08

Market Cap

145.5M

Sector

N/A

ML Signal

N/A

Logo Caribou Biosciences Inc.

CRBU

Caribou Biosciences Inc.

HOLD

Current Price

$1.74

Market Cap

166.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMJF
CRBU
Founded
1988
2011
Country
Singapore
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
145.5M
166.6M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SMJF
CRBU
Price
$5.08
$1.74
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$10.75
AVG Volume (30 Days)
520.3K
2.6M
Earning Date
09-04-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.64
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.63
Revenue Next Year
N/A
$10.93
P/E Ratio
$68.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.82
$1.38
52 Week High
$5.80
$3.53

Technical Indicators

Market Signals
Indicator
SMJF
CRBU
Relative Strength Index (RSI) 48.47 42.82
Support Level $4.84 $1.73
Resistance Level $5.64 $2.04
Average True Range (ATR) 0.26 0.13
MACD -0.07 0.01
Stochastic Oscillator 10.00 31.82

Price Performance

Historical Comparison
SMJF
CRBU

About SMJF SMJ International Holdings Inc. Class A Ordinary Shares

SMJ International Holdings Inc specializes in the sale and distribution of a wide range of flooring products such as carpet tiles, broadloom carpets and vinyl tiles. The company operates under the proprietary brand 'SMJ'.The company also supplies environmentally friendly flooring products, promoting sustainable building practices in Asia. It has presence in several countries including Malaysia, Indonesia, Philippines, Hong Kong, PRC, Taiwan, Korea, Thailand, Vietnam, Brunei, and India. It generates revenue mainly through the sale and distribution of its flooring products prominently in Singapore.

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.

Share on Social Networks: